Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin CA91911K1021
Ticker VRX
Company VALEANT PHARMACEUTICALS INTERNATIONAL
Currency $
Price
Aware Investor Index (AII) 0.0000
Recommendation STRONG SELL
P/E 239.46
ROE 1.20 %
Capitalization 15,616,795,000 $
Dividend Yield 0.00 %
P/S 1.89
AII Position 776
P/E Position 766
ROE Position 779
Capitalization Position 415
Dividend Yield Position 629
Sales 8,263,500,000 $
10-Year Average Earnings 65,217,000 $
Shares Outstanding 341,500,000
Equity 5,434,500,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country Canada
VALEANT PHARMACEUTICALS INTERNATIONAL Investor Relations Web Site http://ir.valeant.com







Sales:

YEAR MONTH AMOUNT
2014 12 8,263,500,000.00 $
2013 12 5,769,605,000.00 $

Earnings:

YEAR MONTH AMOUNT
2014 12 913,500,000.00 $
2013 12 -866,142,000.00 $
2012 12 -116,025,000.00 $
2011 12 159,559,000.00 $
2010 12 -208,193,000.00 $
2009 12 176,455,000.00 $
2008 12 199,904,000.00 $
2007 12 103,541,000.00 $
2006 12 228,939,000.00 $
2005 12 60,632,000.00 $

Equity:

YEAR MONTH AMOUNT
2014 12 5,434,500,000.00 $
2013 12 5,233,322,000.00 $
2012 12 3,717,398,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2014 12 341,500,000
2013 12 320,996,000
2012 12 303,861,000

 












Bloomberg News for VALEANT PHARMACEUTICALS INTERNATIONAL:

Jan 6, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
1500 CVE CENOVUS ENE CVE US 03/19/11 C22.5 17.3 55.9 10.30 -5.5 500 VRX VALEANT PHA VRX US 01/22/11 C32 17.1 38.9 3.30 407.7 1291 CSX CSX CORP CSX US 01/22/11...
Feb 27, 2006
In India, Selling Generics Used To Be So Easy
Jersey, and bought an Ohio factory from California-based Valeant Pharmaceuticals International (VRX ). In December, Bombay's Glenmark Pharmaceuticals announced a deal with InvaGen Pharmaceuticals...
Dec 1, 2003
A New Way To Fight Hepatitis C
better at bypassing the blood cells and going straight to the liver. Valeant Pharmaceuticals (VRX), formerly ICN Pharma-ceuticals (ICN), developed both drugs. And it announced in early November...
Jan 3, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
1368 SSO PROSHARES U SSO US 01/22/11 C40 16.9 53.7 9.27 14.4 517 VRX VALEANT PHA VRX US 01/22/11 C26 16.8 47.4 3.05 -7.6 1000 CSCO CISCO SYSTE CSCO US 01/22/11...
Nov 10, 2011
Zweig Dimenna Partners Holdings in 3rd Quarter: 13F Alert
Freeport-McMoRan Copper FCX US -21,681,938 173,360 -336,295 Valeant Pharmaceuticals Inte VRX US -20,560,233 124,345 -360,180 Williams Cos Inc WMB US -17,574...
Sep 28, 2011
Allon, PetroAmerica, Rare Element, TMX: Canadian Equity Preview
offered to buy TMX for C$3.73 billion ($3.65 billion). Valeant Pharmaceuticals International Inc. (VRX CN): The drugmaker received approval for colesevelam hydrochloride, a treatment to help lower LDL...
Apr 21, 2011
ARC Resources, Celestica, Silver Wheaton: Canada Equity Preview
Steven Butler, an analyst at Canaccord Financial Inc. Valeant Pharmaceuticals International Inc. (VRX CN): Canada‚Äôs largest drugmaker said it is prepared to ‚Äúmodestly‚ÄĚ raise its bid for Cephalon Inc...
May 24, 2011
Eastplats, National Bank of Canada: Canadian Equity Preview
Mario Mendonca, an analyst at Canaccord Financial Inc. Valeant Pharmaceuticals International Inc. (VRX CN): Canada’s biggest drugmaker agreed to buy Lithuania-based AB Sanitas for about 314 million...
Feb 14, 2011
Brahman Capital Corp Largest Holdings in 4th Quarter: 13F Alert
Technologies Holding ST US 70,728,842 2,349,015 2,349,015 Valeant Pharmaceuticals Inte VRX US 65,248,056 2,306,400 -254,700 Xerox Corp XRX US 57,273...
Feb 15, 2011
ValueAct Holdings Largest Holdings in 4th Qtr: 13F Alert
(USD $) Position In Position Valeant Pharmaceuticals Inte VRX US 762,695,599 26,959,901 Sara Lee Corp SLE US 611,428...


Google News for VALEANT PHARMACEUTICALS INTERNATIONAL:

Seeking Alpha - 19 hours ago
It's Time To Talk About Valeant
We're going to assume that our readers already know the Valeant (NYSE:VRX) story, because even if we were qualified to retell it (and we ...
Seeking Alpha - 1 day ago
Valeant Can Beat Guidance
Valeant Pharmaceuticals (NYSE:VRX) has guided pretty bad performance for the full year of 2017, and most of this is because of patent loss of ...
Smarter Analyst - 1 day ago
Valeant Pharmaceuticals Intl Inc's (VRX) Bausch + Lomb Announces ...
Valeant Pharmaceuticals Intl Inc's (NYSE:VRX) wholly owned subsidiary, Bausch ... Valeant Pharmaceuticals International, Inc. engages in the ...
Nasdaq
Valeant Pharmaceuticals International, Inc. (VRX) closed the last ...
Valeant Pharmaceuticals International, Inc. (VRX) added 2.99% to reach $9.29 in the previous trading session. Overall, 16.58 Million shares ...
StandardOracle - 9 hours ago
A Physician Analyzes Valeant's Siliq, As The Stock Crashes
VRX is leading a large group of pharmaceutical roll-up companies, all laden down with debt, lower. No bells are rung at the bottom, and the ...
Equities.com
Valeant Is Unfairly Undervalued II
We modeled the cash flows Valeant (NYSE:VRX) could generate in 2017, 2018 and 2019. Our model of Free Cash Flow to Equity (FCFE) is as ...
HugoPress
Hot Stock for Investors: Valeant Pharmaceuticals International, Inc ...
Morgan Stanley Downgrades Valeant Pharmaceuticals International, Inc. (VRX)'s stock to Equal-Weight with the price target of $17. This rating ...
Seeking Alpha
Valeant: Collapse Imminent
The pharmaceutical industry is showing signs of sector-wide decline as evidenced by weakness in Johnson and Johnson's Q1 result. Johnson ...
Seeking Alpha - 3 days ago
Investors Active Spotlight: Valeant Pharmaceuticals International, Inc ...
Valeant Pharmaceuticals International, Inc. (VRX) stock price distance from twenty day simple moving average slumped at -4.36% while its ...
Seeking Alpha - 3 days ago
Valeant Pharmaceuticals Intl Inc's (VRX) PAPC Announces Pricing ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced that following the ... Valeant Pharmaceuticals International, Inc. engages in the ...


Back